WallStSmart
CYCC

Cyclacel Pharmaceuticals Inc

NASDAQ: CYCCP · HEALTHCARE · BIOTECHNOLOGY

$5.05
+0.00% today

Updated 2026-04-30

Market cap
$9.60M
P/E ratio
P/S ratio
960.24x
EPS (TTM)
$-2.05
Dividend yield
52W range
$3 – $9
Volume

Cyclacel Pharmaceuticals Inc (CYCCP) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Revenue$356000.00$387000.00$129000.00$877000.00$911000.00$686000.00$699000.00$69000.00$1.08M$1.73M$1.94M$843000.00$0.00$150000.00$0.00$5877.00$0.00$373000.00$420000.00$43000.00
Revenue growth (YoY)+8.7%-66.7%+579.8%+3.9%-24.7%+1.9%-90.1%+1471.0%+60.0%+12.1%-56.6%-100.0%-100.0%-100.0%+12.6%-89.8%
Cost of revenue$1.32M$1.12M$1.12M$2.29M$1.21M$875000.00$360000.00$6.59M$11.28M$18.28M$12.38M$9.48M$4.24M$4.33M$4.66M$20000.00$43000.00$32000.00$32000.00$6000.00
Gross profit$-966000.00$-737000.00$-995000.00$-1.41M$-302000.00$-189000.00$339000.00$-6.52M$-10.19M$-16.54M$-10.44M$-8.63M$-4.24M$-4.18M$-4.66M$-20000.00$-43000.00$-32000.00$420000.00$43000.00
Gross margin-271.3%-190.4%-771.3%-161.2%-33.2%-27.6%48.5%-9453.6%-940.3%-954.0%-536.9%-1024.2%-2784.7%-340.3%-8.6%100.0%100.0%
R&D$15.84M$21.20M$19.57M$18.87M$9.77M$6.41M$9.21M$6.59M$11.28M$18.28M$12.38M$9.48M$4.24M$4.33M$4.66M$4.74M$14.93M$20.27M$19.16M$6.66M
SG&A$9.67M$12.32M$11.54M$15.35M$8.54M$10.12M$7.52M$8.58M$7.78M$5.89M$5.73M$5.52M$5.25M$5.37M$5.02M$5.88M$7.46M$7.38M$6.72M$5.39M
Operating income$-20.77M$-33.14M$-30.98M$-33.77M$-17.94M$-16.27M$-16.39M$-15.10M$-17.97M$-22.44M$-16.17M$-14.15M$-9.49M$-9.55M$-9.68M$-10.64M$-22.39M$-27.66M$-25.45M$-12.00M
Operating margin-5835.7%-8562.5%-24017.8%-3851.2%-1969.0%-2371.1%-2344.5%-21888.4%-1658.1%-1293.9%-831.8%-1678.5%-6365.3%-180976.7%-7414.5%-6060.2%-27916.3%
EBITDA$-18.57M$-30.13M$-24.75M$-39.95M$-19.67M$-16.18M$-15.57M$-15.05M$-11.81M$-22.26M$-15.96M$-14.02M$-9.46M$-9.52M$-9.66M$-9.66M$-22.35M$-27.62M$-25.42M$-12.00M
EBITDA margin-5215.2%-7784.2%-19183.7%-4555.9%-2159.5%-2358.3%-2227.0%-21807.2%-1089.5%-1283.9%-821.0%-1662.8%-6346.0%-164386.6%-7405.9%-6052.9%-27902.3%
EBIT$-19.89M$-31.25M$-25.87M$-41.82M$-20.34M$-16.63M$-15.81M$-15.11M$-11.88M$-22.44M$-16.17M$-14.15M$-9.49M$-9.55M$-9.68M$-9.68M$-22.39M$-27.66M$-25.45M$-12.00M
Interest expense$60000.00$254000.00$223000.00$318000.00$177000.00$43000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$677000.00$997000.00$291000.00$2.01M$2.01M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-18.05M$-29.26M$-24.05M$-40.39M$-19.57M$-16.02M$-15.24M$-13.19M$-10.15M$-19.39M$-14.34M$-11.79M$-7.47M$-7.29M$-7.83M$-8.45M$-18.46M$-21.20M$-22.55M$-11.21M
Net income growth (YoY)-62.1%+17.8%-67.9%+51.5%+18.1%+4.9%+13.5%+23.0%-90.9%+26.0%+17.8%+36.6%+2.4%-7.4%-7.9%-118.6%-14.9%-6.4%+50.3%
Profit margin-5069.7%-7560.2%-18645.7%-4605.0%-2148.2%-2335.4%-2180.7%-19110.1%-936.6%-1118.1%-737.8%-1398.7%-4858.7%-143695.8%-5683.1%-5370.2%-26074.4%